Garamszegi brings over 16 years of executive experience in the medical device industry. He has co-founded several, successful medical device start-up companies, where he then served as Chief Technology Officer and VP of Engineering. He established the Product Development, Quality, Regulatory, and Manufacturing departments for his companies, and during this time he launched 13 FDA 510(k)-cleared implant products. Mr. Garamszegi has also been awarded six US patents for his spinal implant designs and has over 10 patents pending; most of these inventions were commercialized and sold for over $60 million in the US. He is the co-inventor of the 4Closureâ„£ Laparoscopic Fascia Closure Device, a technology that was sold to Synovis Life Technologies in 2007 (NYSE: SYNO). Mr. Garamszegi received his Manufacturing Engineering Technology degree from Banki Donat Technical Institute in Hungary.  Garamszegi brings over 16 years of executive experience in the medical device industry. He has co-founded several, successful medical device start-up companies, where he then served as Chief Technology Officer and VP of Engineering. He established the Product Development, Quality, Regulatory, and Manufacturing departments for his companies, and during this time he launched 13 FDA 510(k)-cleared implant products. Mr. Garamszegi has also been awarded six US patents for his spinal implant designs and has over 10 patents pending; most of these inventions were commercialized and sold for over $60 million in the US. He is the co-inventor of the 4Closureâ„£ Laparoscopic Fascia Closure Device, a technology that was sold to Synovis Life Technologies in 2007 (NYSE: SYNO). Mr. Garamszegi received his Manufacturing Engineering Technology degree from Banki Donat Technical Institute in Hungary.

fermentation